Leadless cardiac pacing: Results from a large single-centre experience - 20/07/23
, Kassem Abou Khalil a, Alexandre Bodin a, Dominique Babuty a, Arnaud Bisson a, b, Nicolas Clementy cGraphical abstract |
Highlights |
• | Leadless cardiac pacing is an alternative to conventional pacing. |
• | Perioperative complications were low in a 400-patient cohort. |
• | Long-term electrical parameters were excellent. |
• | Leadless cardiac pacing appears safe and effective in the long-term. |
Abstract |
Background |
The efficacy and safety of leadless cardiac pacing as an alternative to conventional transvenous cardiac pacing in selected patients have been widely reported.
Aim |
To report the experience of a high-volume implantation centre with older and new generations of leadless pacemakers.
Methods |
This retrospective observational study included the first consecutive 400 patients who underwent implantation of a leadless pacemaker in our centre. Complications and electrical parameters were evaluated during follow-up, comparing patients implanted with first-generation (Micra™ VR) and second-generation (Micra™ AV) leadless pacemakers (Medtronic, Minneapolis, MN, USA). Data were collected by a review of medical files.
Results |
Among 400 procedures, there were 328 Micra™ VR pacemakers and 72 Micra™ AV pacemakers implanted, followed for a median of 16 months (694 patient-years). The mean age was 77 years and both groups had a high burden of co-morbidities. Implantation success rate was 99.5%. A total of 87.5% of patients were discharged the day after the procedure. The pacing threshold remained stable and < 2 V in 96.5% of all patients. The perioperative complication rate at 30 days was 3.5%. Outcomes were similar between the two groups.
Conclusion |
Leadless cardiac pacing is a safe and efficient alternative to conventional transvenous cardiac pacing.
Le texte complet de cet article est disponible en PDF.Keywords : Leadless pacing, Periprocedural complications, Long-term complications
Abbreviation : AV
Plan
| ☆ | Tweet: The results of the largest single-centre cohort of patients implanted with a leadless pacemaker, supporting its safety and efficacy. Twitter handle: @clementy_ep (N. Clementy).. |
Vol 116 - N° 6-7
P. 316-323 - juin 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
